The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy

doi:10.1038/srep03098

Paper

DOI: 10.1038/srep03098

The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy

Published Nov 14, 2013 · Y. Liu, Wei Cao, Bo Zhang

Scientific Reports

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Highly Cited

Study Snapshot

Magnolol, a natural compound found in medicinal herbs, inhibits breast cancer cell invasion by downregulating MMP-9 and NF-B pathways, exhibiting potential in human breast cancer therapy.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Full text analysis coming soon...

References

DOI: 10.1158/0008-5472.CAN-12-1699

Genetic susceptibility to triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is associated with a unique pattern of common and rare germline predisposition alleles, highlighting the need for further genetic and epidemiologic research to better understand its etiology and develop risk prediction models.

2013·195citations·Kristen Stevens et al.·Cancer research

Cancer research

DOI: 10.1371/journal.pone.0048748

Gefitinib Analogue V1801 Induces Apoptosis of T790M EGFR-Harboring Lung Cancer Cells by Up-Regulation of the BH-3 Only Protein Noxa

V1801, a weak gefitinib analogue, overcomes drug-resistance in non-small cell lung cancer cells by activating BH-3-only pro-apoptotic proteins, offering potential therapeutic potential for this cancer type.

2012·10citations·Bo Zhang et al.·PLoS ONE

PLoS ONE

DOI: 10.1371/journal.pone.0047049

Identification of an Annonaceous Acetogenin Mimetic, AA005, as an AMPK Activator and Autophagy Inducer in Colon Cancer Cells

AA005 is a potent antitumor agent that inhibits colon cancer cell growth and induces autophagy by activating AMPK and inhibiting mTORC1.

2012·40citations·Yong-Qiang Liu et al.·PLoS ONE

PLoS ONE

DOI: 10.1016/j.canlet.2012.03.004

Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.

Gambogenic acid (GEA) inhibits lung cancer cell growth and induces autophagy, potentially offering chemopreventive and therapeutic potential for lung cancer.

2012·79citations·Xian-jun Yu et al.·Cancer letters

Cancer letters

DOI: 10.1002/jcb.24159

N‐(4‐hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF‐KB activation and inhibiting matrix metalloproteinase‐9 expression

N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion by suppressing MMP-9 expression and NF-B signaling pathway.

2012·31citations·Hyereen Kang et al.·Journal of Cellular Biochemistry

Journal of Cellular Biochemistry

Citations

DOI: 10.3390/biomedicines12030482

Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness

Dietary polyphenols from plant-based foods and beverages may have antitumoral effects by targeting key mechanisms involved in cancer progression and reducing cancer cells' invasiveness.

2024·3citations·Raffaele Carrano et al.·Biomedicines

Biomedicines

DOI: 10.1016/j.canlet.2023.216590

Natural compounds modulating mitophagy: Implications for cancer therapy.

Natural compounds can potentially enhance cancer therapy by modulating mitophagy, offering potential new treatment strategies.

2023·14citations·Min Cao et al.·Cancer letters

Cancer letters

DOI: 10.1016/j.biopha.2023.115722

Potential of alisols as cancer therapeutic agents: Investigating molecular mechanisms, pharmacokinetics and metabolism.

Alisols show promising anti-cancer properties, suppressing cancer cell proliferation and migration, with minimal side effects and low drug resistance.

2023·1citation·Yinqi Wu et al.·Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

DOI: 10.1016/j.jddst.2023.105078

Self-assembled supramolecular nanoparticle by host-guest interaction for thermo-controlled released of magnolol in cancer chemotherapy

FA-PPG--CD supramolecular nanoparticles with magnolol effectively control drug release, enhancing cancer chemotherapy efficacy and low toxicity to normal cells.

2023·5citations·F. B. Ilhami et al.·Journal of Drug Delivery Science and Technology

Journal of Drug Delivery Science and Technology

DOI: 10.1016/j.bbadis.2023.166782

Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition.

Magnolol and Temozolomide show synergistic anti-glioma activity by inhibiting MGMT enzyme activation through NF-B pathway inhibition.

2023·5citations·Moumita Kundu et al.·Biochimica et biophysica acta. Molecular basis of disease

Biochimica et biophysica acta. Molecular basis of disease

DOI: 10.3390/pharmaceutics15051461

10-Hydroxy Decanoic Acid-Based Vesicles as a Novel Topical Delivery System: Would It Be a Better Platform Than Conventional Oleic Acid Ufasomes for Skin Cancer Treatment?

HDA-based vesicles show potential as a better topical delivery system for skin cancer treatment, with enhanced permeation and drug retention compared to conventional oleic acid ufasomes.

2023·6citations·Bassant Atef et al.·Pharmaceutics

Pharmaceutics

DOI: 10.3390/medicina59020286

Evaluating the Magnolol Anticancer Potential in MKN-45 Gastric Cancer Cells

Magnolol has a remarkable anti-tumor effect on MKN-45 gastric cancer cells, and when combined with cisplatin, may help overcome cisplatin resistance in gastric cancer cells.

2023·1citation·Mahsa Naghashpour et al.·Medicina

Medicina